View Item 

Show simple item record

Expression and Function of Aminopeptidase N/CD13 Produced by Fibroblast‐like Synoviocytes in Rheumatoid Arthritis: Role of CD13 in Chemotaxis of Cytokine‐Activated T Cells Independent of Enzymatic Activity
dc.contributor.authorMorgan, Rachelen_US
dc.contributor.authorEndres, Judithen_US
dc.contributor.authorBehbahani‐nejad, Nilofaren_US
dc.contributor.authorPhillips, Kristineen_US
dc.contributor.authorRuth, Jeffrey H.en_US
dc.contributor.authorFriday, Sean C.en_US
dc.contributor.authorEdhayan, Gautamen_US
dc.contributor.authorLanigan, Thomasen_US
dc.contributor.authorUrquhart, Andrewen_US
dc.contributor.authorChung, Kevin C.en_US
dc.contributor.authorFox, David A.en_US
dc.date.accessioned2015-01-07T15:23:57Z
dc.date.available2016-03-02T19:36:56Zen
dc.date.issued2015-01en_US
dc.identifier.citationMorgan, Rachel; Endres, Judith; Behbahani‐nejad, Nilofar ; Phillips, Kristine; Ruth, Jeffrey H.; Friday, Sean C.; Edhayan, Gautam; Lanigan, Thomas; Urquhart, Andrew; Chung, Kevin C.; Fox, David A. (2015). "Expression and Function of Aminopeptidase N/CD13 Produced by Fibroblastâ like Synoviocytes in Rheumatoid Arthritis: Role of CD13 in Chemotaxis of Cytokineâ Activated T Cells Independent of Enzymatic Activity." Arthritis & Rheumatology 67(1): 74-85.en_US
dc.identifier.issn2326-5191en_US
dc.identifier.issn2326-5205en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109947
dc.publisherWiley Periodicals, Inc.en_US
dc.titleExpression and Function of Aminopeptidase N/CD13 Produced by Fibroblast‐like Synoviocytes in Rheumatoid Arthritis: Role of CD13 in Chemotaxis of Cytokine‐Activated T Cells Independent of Enzymatic Activityen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelRheumatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109947/1/art38878.pdf
dc.identifier.doi10.1002/art.38878en_US
dc.identifier.sourceArthritis & Rheumatologyen_US
dc.identifier.citedreferenceMantle D, Falkous G, Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999; 284: 45 – 58.en_US
dc.identifier.citedreferenceMina‐Osorio P. The moonlighting enzyme CD13: old and new functions to target [review]. Cell 2008; 14: 361 – 71.en_US
dc.identifier.citedreferenceRuth JH, Rottman JB, Katschke KJ Jr, Qin S, Wu L, LaRosa G, et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001; 44: 2750 – 60.en_US
dc.identifier.citedreferenceScornik OA, Botbol V. Bestatin as an experimental tool in mammals. Curr Drug Metab 2001; 2: 67 – 85.en_US
dc.identifier.citedreferenceIsozaki T, Ruth JH, Amin MA, Campbell PL, Tsou PS, Ha CM, et al. Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Res Ther 2014; 16: R28.en_US
dc.identifier.citedreferenceArnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315 – 24.en_US
dc.identifier.citedreferenceBrennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine‐activated T cells: involvement of phosphatidylinositol 3‐kinase and nuclear factor κB pathways in tumor necrosis factor α production in rheumatoid arthritis. Arthritis Rheum 2002; 46: 31 – 41.en_US
dc.identifier.citedreferenceBryant J, Ahern DJ, Brennan FM. CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine‐activated T cells. Arthritis Rheum 2012; 64: 2137 – 46.en_US
dc.identifier.citedreferenceFreidman AW, Diaz LA Jr, Moore S, Schaller J, Fox DA. The human 4F2 antigen: evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol 1994; 154: 253 – 63.en_US
dc.identifier.citedreferenceNelson RD, Quie PG, Simmons RL. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975; 115: 1650 – 6.en_US
dc.identifier.citedreferenceHeit B, Kubes P. Measuring chemotaxis and chemokinesis: the under‐agarose cell migration assay. Sci STKE 2003; 2003: PL5.en_US
dc.identifier.citedreferenceTani K, Ogushi F, Huang L, Kawano T, Tada H, Hariguchi N, et al. CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 161: 1636 – 42.en_US
dc.identifier.citedreferenceLuciani N, Marie‐Claire C, Ruffet E, Beaumont A, Roques BP, Fournie‐Zaluski MC. Characterization of Glu 350 as a critical residue involved in the N‐terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action. Biochemistry 1998; 37: 686 – 92.en_US
dc.identifier.citedreferenceAllen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007; 25: 787 – 820.en_US
dc.identifier.citedreferenceLuan Y, Xu W. The structure and main functions of aminopeptidase N. Curr Med Chem 2007; 14: 639 – 47.en_US
dc.identifier.citedreferenceBrown SB, Kluck RM, Ellem KA. Loss and shedding of surface markers from the leukemic myeloid monocytic line THP‐1 induced to undergo apoptosis. J Cell Biochem 1996; 60: 246 – 59.en_US
dc.identifier.citedreferenceMiossec P, Dinarello CA, Ziff M. Interleukin‐1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986; 29: 461 – 70.en_US
dc.identifier.citedreferenceAl‐Mughales J, Blyth TH, Hunter JA, Wilkinson PC. The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines. Clin Exp Immunol 1996; 106: 230 – 6.en_US
dc.identifier.citedreferenceKanayama N, Kajiwara Y, Goto J, Maradny EE, Maehara K, Andou K, et al. Inactivation of interleukin‐8 by aminopeptidase N (CD13). J Leukoc Biol 1995; 57: 129 – 34.en_US
dc.identifier.citedreferenceWulfaenger J, Niedling S, Riemann D, Seliger B. Aminopeptidase N (APN)/CD13‐dependent CXCR4 downregulation is associated with diminished cell migration, proliferation, and invasion. Mol Membr Biol 2008; 25: 72 – 82.en_US
dc.identifier.citedreferenceChomarat P, Rissoan MC, Pin JJ, Banchereau J, Miossec P. Contribution of IL‐1, CD14, and CD13 in the increased IL‐6 production induced by in vitro monocyte‐synoviocyte interactions. J Immunol 1995; 155: 3645 – 52.en_US
dc.identifier.citedreferenceProost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, et al. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 2007; 110: 37 – 44.en_US
dc.identifier.citedreferenceWong AH, Zhou D, Rini JM. The X‐ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing. J Biol Chem 2012; 287: 36804 – 13.en_US
dc.identifier.citedreferenceAshmun RA, Shapiro LH, Look AT. Deletion of the zinc‐binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies. Blood 1992; 79: 3344 – 49.en_US
dc.identifier.citedreferenceMangmool S, Kurose H. G i/o protein‐dependent and ‐independent actions of pertussis toxin (PTX). Toxins (Basel) 2011; 3: 884 – 99.en_US
dc.identifier.citedreferenceLook AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989; 83: 1299 – 307.en_US
dc.identifier.citedreferenceRiemann D, Kehlen A, Langner J. CD13: not just a marker in leukemia typing [review]. Immunol Today 1999; 20: 83 – 8.en_US
dc.identifier.citedreferenceFavaloro EJ, Browning T, Facey D. CD13 (GP150; aminopeptidase‐N): predominant functional activity in blood is localized to plasma and is not cell‐surface associated. Exp Hematol 1993; 21: 1695 – 701.en_US
dc.identifier.citedreferenceWatanabe Y, Ito K, Iwaki‐Egawa S, Yamaguchi R, Fujimoto Y. Aminopeptidase N in sera of healthy subjects is a different n‐terminal processed derivative from the one obtained from maternal serum. Mol Genet Metab 1998; 63: 289 – 94.en_US
dc.identifier.citedreferenceLarsen SL, Pedersen LO, Buus S, Stryhn A. T cell responses affected by aminopeptidase N (CD13)‐mediated trimming of major histocompatibility complex class II‐bound peptides. J Exp Med 1996; 184: 183 – 9.en_US
dc.identifier.citedreferenceSaiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, et al. Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation. Int J Cancer 1993; 54: 137 – 43.en_US
dc.identifier.citedreferenceDan H, Tani K, Hase K, Shimizu T, Tamiya H, Biraa Y, et al. CD13/aminopeptidase N in collagen vascular diseases. Rheumatol Int 2003; 23: 271 – 6.en_US
dc.identifier.citedreferenceShimizu T, Tani K, Hase K, Ogawa H, Huang L, Shinomiya F, et al. CD13/aminopeptidase N–induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 2330 – 8.en_US
dc.identifier.citedreferenceKitko CL, Levine JE, Storer BE, Chai X, Fox D, Braun TM, et al. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. Blood 2014; 123: 786 – 93.en_US
dc.identifier.citedreferenceThielitz A, Ansorge S, Bank U, Tager M, Wrenger S, Gollnick H, et al. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases. Front Biosci 2008; 13: 2364 – 75.en_US
dc.identifier.citedreferenceLundy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheumatoid arthritis: T lymphocytes [review]. Arthritis Res Ther 2007; 9: 202.en_US
dc.identifier.citedreferenceVan Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM, et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A production. Arthritis Rheum 2011; 63: 73 – 83.en_US
dc.identifier.citedreferenceKim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, et al. Up‐regulation of stromal cell–derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin‐17 and CD40L–CD40 interaction. Arthritis Rheum 2007; 56: 1076 – 86.en_US
dc.identifier.citedreferenceSzekanec Z, Koch AE, Tak PP. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune‐mediated inflammatory diseases [review]. Neth J Med 2011; 69: 356 – 66.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art38878.pdf
Size:
650.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.